Status: Phase 2
Entry Type: Unknown
Molecule Category: UNKNOWN
UNII: H1396W7D1H

Indications

Mesh Heading Maximum Phase Reference
Hodgkin Disease; Lymphoma; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin Phase 1/Phase 2 ClinicalTrials
Carcinoma, Non-Small-Cell Lung; Lung Neoplasms Phase 2 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL4297784
FDA SRS H1396W7D1H